RK

Rajesh Kumar Singh

Active Director Director DIN 06975751
DIN 06975751 First appointment Oct 2014 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2014
Shareholding value β€’β€’β€’β€’ Premium profile

About Rajesh Kumar Singh

Data last updated:

Rajesh Kumar Singh is a Director at Ista Pharmaceuticals Private Limited (since 2014). The company operates in Chemicals.

DIN 06975751
Primary Designation Director
Industry Chemicals
First Appointment 17 Oct 2014
Oldest Company Age 12 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ista Pharmaceuticals Private Limited U24232MP2014PTC033325
Director17 Oct 20142014Dormant Under Section 455

Board colleagues of Rajesh Kumar Singh

Directorship timeline

Open interactive timeline →
Ista Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rajesh Kumar Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajesh Kumar Singh

Rajesh Kumar Singh currently holds 1 directorship: Ista Pharmaceuticals Private Limited (Director, since 17 Oct 2014).

Rajesh Kumar Singh was first appointed on 17 Oct 2014 as Director at Ista Pharmaceuticals Private Limited.

The current boards of Rajesh Kumar Singh's companies include Kashif Ahmed (Ista Pharmaceuticals Private Limited), Sudhir Kumar Dhaple (Ista Pharmaceuticals Private Limited), Vivek Sharma (Ista Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available